Differentiation therapy - PubMed

Review

Differentiation therapy

Alexander I Spira et al. Curr Opin Pharmacol. 2003 Aug.

Abstract

Differentiation therapy is an area of oncology that is in its infancy. Theoretically, the concept of differentiation therapy involves turning a cancer cell "off" biologically and reverting to a more "benign" phenotype. Many agents have been studied over the past few years, with many already either in use clinically or showing future promise.

Similar articles

• Differentiation agents in cancer therapy.

  Ferrari AC, Waxman S. Ferrari AC, et al. Cancer Chemother Biol Response Modif. 1994;15:337-66. Cancer Chemother Biol Response Modif. 1994. PMID: 7779589 Review. No abstract available.

• Retinoids.

  Holdener EE, Bollag W. Holdener EE, et al. Curr Opin Oncol. 1993 Nov;5(6):1059-66. doi: 10.1097/00001622-199311000-00019. Curr Opin Oncol. 1993. PMID: 8305540 Review.

• Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors.

  Gore SD, Carducci MA. Gore SD, et al. Expert Opin Investig Drugs. 2000 Dec;9(12):2923-34. doi: 10.1517/13543784.9.12.2923. Expert Opin Investig Drugs. 2000. PMID: 11093362 Review.

• Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents.

  Garattini E, Gianni' M, Terao M. Garattini E, et al. Vitam Horm. 2007;75:301-54. doi: 10.1016/S0083-6729(06)75012-9. Vitam Horm. 2007. PMID: 17368321 Review.

• Differentiation therapy in acute myelogenous leukemia (non-APL).

  Waxman S. Waxman S. Leukemia. 2000 Mar;14(3):491-6. doi: 10.1038/sj.leu.2401714. Leukemia. 2000. PMID: 10720148 Review.

Cited by

• Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma.

  Zhang Y, Song WJ, Zhang FQ, Liu WH, Dou KF. Zhang Y, et al. Dig Dis Sci. 2011 Aug;56(8):2473-81. doi: 10.1007/s10620-011-1601-6. Epub 2011 Feb 12. Dig Dis Sci. 2011. PMID: 21318586

• p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

  Saunthararajah Y, Triozzi P, Rini B, Singh A, Radivoyevitch T, Sekeres M, Advani A, Tiu R, Reu F, Kalaycio M, Copelan E, Hsi E, Lichtin A, Bolwell B. Saunthararajah Y, et al. Semin Oncol. 2012 Feb;39(1):97-108. doi: 10.1053/j.seminoncol.2011.11.011. Semin Oncol. 2012. PMID: 22289496 Free PMC article. Review.

• Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity.

  Park CR, Lee M, Lee SY, Kang D, Park SJ, Lee DC, Koo H, Park YG, Yu SL, Jeong IB, Kwon SJ, Kang J, Lee EB, Son JW. Park CR, et al. Noncoding RNA Res. 2023 Mar 9;8(3):273-281. doi: 10.1016/j.ncrna.2023.03.001. eCollection 2023 Sep. Noncoding RNA Res. 2023. PMID: 36949748 Free PMC article.

• Clinical and experimental applications of sodium phenylbutyrate.

  Iannitti T, Palmieri B. Iannitti T, et al. Drugs R D. 2011 Sep 1;11(3):227-49. doi: 10.2165/11591280-000000000-00000. Drugs R D. 2011. PMID: 21902286 Free PMC article. Review.

• Liver stem cells and hepatocellular carcinoma.

  Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP. Mishra L, et al. Hepatology. 2009 Jan;49(1):318-29. doi: 10.1002/hep.22704. Hepatology. 2009. PMID: 19111019 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Miscellaneous

  • NCI CPTAC Assay Portal